主记录
GSK-1004723
- CAS
- 955359-72-5
- PubChem CID
- 17747460
- SMILES
- C1CCCN(CC1)CCCOC2=CC=C(C=C2)CCCCN3CCC[C@@H]3CN4C(=O)C5=CC=CC=C5C(=N4)CC6=CC=C(C=C6)Cl
- 分子式
- C39H49ClN4O2
- 分子量
- 641.3
- 精确分子量
- 640.3544
- InChI
- InChI=1S/C39H49ClN4O2/c40-33-19-15-32(16-20-33)29-38-36-13-3-4-14-37(36)39(45)44(41-38)30-34-12-9-27-43(34)26-8-5-11-31-17-21-35(22-18-31)46-28-10-25-42-23-6-1-2-7-24-42/h3-4,13-22,34H,1-2,5-12,23-30H2/t34-/m1/s1
- InChIKey
- YANGEESWIGIKOP-UUWRZZSWSA-N
- LogP
- 7.7729
- TPSA
- 50.6
名称与别名
- GSK-1004723
- GSK1004723
- UNII-S08212J4ZR
- RefChem:144500
- S08212J4ZR
- CHEMBL1767164
- GSK 1004723
- SCHEMBL986140
- 955359-72-5
- YANGEESWIGIKOP-UUWRZZSWSA-N
- orb1700488
- GLXC-07559
- 932373-87-0(free base)
- BDBM50341447
- AKOS040748453
- DB12806
- GSK-1034702
- CS-0021741
- NS00072523
- 1(2H)-Phthalazinone, 4-((4-chlorophenyl)methyl)-2-(((2R)-1-(4-(4-(3-(hexahydro-1H-azepin-1-yl)propoxy)phenyl)butyl)-2-pyrrolidinyl)methyl)-
- Q27288388
- (R)-2-((1-(4-(4-(3-(azepan-1-yl)propoxy)phenyl)butyl)pyrrolidin-2-yl)methyl)-4-(4-chlorobenzyl)phthalazin-1(2H)-one
- 2-[[(2R)-1-[4-[4-[3-(azepan-1-yl)propoxy]phenyl]butyl]pyrrolidin-2-yl]methyl]-4-[(4-chlorophenyl)methyl]phthalazin-1-one
- 4-[(4-chlorophenyl)methyl]-2-({(2r)-1-[4-(4-{[3-(hexahydro-1h-azepin-1-yl)propyl]oxy}phenyl)butyl]-2-pyrrolidinyl}methyl)-1(2h)-phthalazinone
- 2-(((2R)-1-(4-(4-(3-(azepan-1-yl)propoxy)phenyl)butyl)pyrrolidin-2-yl)methyl)-4-((4-chlorophenyl)methyl)-1,2-dihydrophthalazin-1-one
- 4-Fluoro-6-methyl-1-(1-(tetrahydro-2H-pyran-4-yl)-4-piperidinyl)-1,3-dihydro-2H-benzimidazol-2-one
- 932373-87-0